Skip to content

A study of chronic kidney disease in a rural area in India

Clinico Epidemiological Profile of Patients with CKDu in a Tertiary Care Centre in a Rural Area in Central India - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/07/071002
Enrollment
100
Registered
2024-07-22
Start date
Unknown
Completion date
Unknown
Last updated
2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N189- Chronic kidney disease, unspecified

Interventions

Intervention1: NIL: NIL Control Intervention1: NIL: NIL

Sponsors

Datta Meghe Institute of Higher Education and Research
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All patients of Chronic Kidney Disease between the age of 18 years and 70 years with estimated glomerular filtration rate (eGFR) by creatinine-based CKD Epidemiology Collaboration (CKD-EPIcr2009)equation of 5 mL/min/1.73m2 to 60 mL/min/1.73m2. Patients voluntarily willing to give informed consent will be taken for this study.

Exclusion criteria

Exclusion criteria: Patients less than 18 years of age. Patients with other known causes of CKD. Organ transplant recipients. Patients with malignancy. Pregnant females. Patients on current immunosuppressive therapy.

Design outcomes

Primary

MeasureTime frame
The primary outcome of the study could be defined as the study of the clinical and epidemiological profile of patients with CKD of Undetermined Etiology(CKDu).Timepoint: Baseline and 12 weeks

Secondary

MeasureTime frame
Secondary outcomes include the study of various biochemical and radiological parameters in patients of CKD of Undetermined Etiology(CKDu). Timepoint: 12 weeks

Countries

India

Contacts

Public ContactDr Shubham Dubey

Datta Meghe Institute of Higher Education and Research

balwani.manish@yahoo.com9924980546

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026